What Is Semax? - SourcePeptides.co Skip to content
FREE SHIPPING. NO MINIMUM PURCHASE REQUIRED

What Is Semax?

What Is Semax?

Semax is a synthetic heptapeptide derived from the N-terminal fragment of ACTH(4-7), with a proline-glycine-proline (PGP) extension added to improve stability and bioavailability in research models.

🎫 First order? Save 25% with code WELCOMEHOME at checkout
Research compounds discussed in this guide
Semax - 5MG
Semax — 5MG

Semax - 5MG — Research-Grade Reference Material Semax - 5MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…

$35.00 ($26.25 With Your 1st Order)
View Research Data
For research use only · 3rd-party tested · Free 2-5 day US shipping

Its full sequence is: Met-Glu-His-Phe-Pro-Gly-Pro

In research settings, Semax is frequently discussed in relation to:

  • Brain-derived neurotrophic factor (BDNF) upregulation models
  • Nerve growth factor (NGF) signaling pathways
  • Neuroprotective mechanism studies
  • Cognitive function and memory consolidation research
  • Cerebrovascular signaling models
  • Neuroinflammation pathway research
  • Dopaminergic and serotonergic system interaction studies

Unlike many peptides that operate peripherally, Semax research is primarily focused on central nervous system (CNS) signaling environments, making it a distinct compound in the broader peptide research landscape.

🔗 View our Semax Products:

🔬 Supporting research:

🎫 First order? Save 25% with code WELCOMEHOME at checkout
Research compounds discussed in this guide
Semax - 5MG
Semax — 5MG

Semax - 5MG — Research-Grade Reference Material Semax - 5MG is supplied as a lyophilized powder for in-vitro laboratory research use only. SourcePeptides supplies this material strictly as a laboratory reference standard.…

$35.00 ($26.25 With Your 1st Order)
View Research Data
For research use only · 3rd-party tested · Free 2-5 day US shipping

Frequently Asked Questions About Semax

What is Semax?

Semax is a synthetic heptapeptide derived from a fragment of adrenocorticotropic hormone (ACTH 4-7) with a proline-glycine-proline (PGP) extension. It is studied in laboratory research settings for its effects on BDNF signaling, neuroprotective pathways, and cognitive function models.

How does Semax work in research models?

Semax is primarily studied for its influence on brain-derived neurotrophic factor (BDNF) upregulation, melanocortin receptor (MC4R) interaction, and neuroprotective signaling cascades. Research models have also examined its effects on dopaminergic and serotonergic system modulation in CNS environments.

What is the difference between Semax and Selank?

Semax and Selank are both synthetic peptides studied in CNS research, but they operate through different mechanisms. Semax is primarily studied for BDNF signaling and neuroprotective pathways, while Selank is more frequently examined in the context of anxiolytic signaling, GABA system modulation, and immune-neuro interaction models.

What research environments is Semax used in?

Semax appears frequently in cognitive function research, ischemia and stroke models, neuroinflammation studies, memory consolidation frameworks, and oxidative stress signaling research. Its BDNF-upregulating properties make it particularly relevant in neuroplasticity and neuroprotection laboratory settings.

What is the ACTH connection in Semax research?

Semax is derived from ACTH(4-7), a fragment of adrenocorticotropic hormone. Importantly, it interacts with melanocortin receptors (particularly MC4R) without activating the hypothalamic-pituitary-adrenal (HPA) axis — making it a useful research tool for studying ACTH-related signaling pathways in isolation from cortisol and adrenal responses.

Can Semax and Selank be studied together?

Yes. Some research models explore Semax and Selank in combination to examine overlapping and complementary CNS signaling pathways — particularly where BDNF upregulation (Semax) and GABAergic modulation (Selank) may interact in stress-response and cognitive function frameworks.

What formats is Semax available in for research?

Semax is commonly supplied as a lyophilized powder or nasal spray formulation for laboratory use. Research procurement typically includes batch-specific Certificates of Analysis (COA), concentration documentation, and research-use-only labeling.

Is Semax intended for human use?

No. Semax is supplied for laboratory and analytical research use only. It is not approved for human or veterinary use. This content is educational and does not constitute medical advice.


How Semax Works: Key Mechanisms in Research Models

Semax is thought to exert its effects through several overlapping signaling pathways that have been explored extensively in preclinical and laboratory settings.

1. BDNF and Neurotrophin Signaling

One of the most studied mechanisms of Semax involves its interaction with brain-derived neurotrophic factor (BDNF). In animal models, Semax administration has been associated with increased BDNF expression in hippocampal regions — areas frequently studied in the context of memory consolidation and neuroplasticity modeling.

BDNF plays a critical role in neuronal survival, synaptic plasticity, and long-term potentiation (LTP) — all key targets in cognitive neuroscience research.

🔬 Supporting research:

2. ACTH Receptor Pathway Interaction

As an ACTH-derived fragment, Semax interacts with melanocortin receptors (MCRs) — particularly MC4R — without triggering adrenocortical activity. This selective receptor interaction is a key area of interest in research models examining stress-response signaling and neuromodulatory pathways without HPA axis activation.

3. Neuroprotective Signaling

Multiple laboratory studies have examined Semax in ischemia and oxidative stress models. Research has explored its potential role in:

  • Reducing neuroinflammatory signaling markers
  • Modulating oxidative stress response cascades
  • Supporting neuronal survival signaling in hypoxic models
  • Cerebral blood flow regulation models

4. Dopaminergic and Serotonergic System Interaction

Semax has been studied in relation to monoaminergic system modulation. Research models have examined its interaction with dopamine receptor signaling and serotonin pathway regulation — pathways frequently targeted in mood and cognitive function research frameworks.


Semax vs Other Nootropic Peptides: Research Positioning

Feature Semax Selank GHK-Cu
Origin ACTH(4-7) fragment + PGP Tuftsin fragment analog Naturally occurring tripeptide
Primary research focus BDNF signaling, neuroprotection Anxiety-related signaling, GABA modulation Collagen, ECM, tissue remodeling
CNS relevance Primary Primary Secondary
Neurotrophin interaction BDNF, NGF BDNF (indirect) Limited
Study environments Cognitive, ischemia, stress models Anxiety, immune, stress models Wound, skin, connective tissue models

⚡ UNLOCK 25% OFF YOUR FIRST ORDER
Create a free account — get new-customer pricing on every research peptide, plus new research summaries delivered to your inbox.
For research use only. No spam — unsubscribe anytime.

Semax in Cognitive and Memory Research Models

A significant portion of Semax research has focused on cognitive performance environments — specifically memory consolidation, attention, and learning pathway models.

Laboratory studies have examined Semax in the context of:

  • Spatial memory task performance in rodent models
  • Long-term potentiation (LTP) enhancement frameworks
  • Working memory signaling pathway studies
  • Attention regulation models in stress environments

The BDNF upregulation mechanism is considered a primary driver of Semax’s relevance in cognitive research — as BDNF is widely studied as a key modulator of synaptic strength and neuroplasticity.

🔬 Supporting research:


Semax in Neuroprotection and Ischemia Research

Beyond cognitive research, Semax has attracted considerable attention in neuroprotection models — particularly ischemic injury and oxidative stress environments.

Studies in rodent ischemia models have explored Semax in relation to:

  • Reduction of infarct volume markers in cerebral ischemia models
  • Neuroinflammatory cytokine signaling modulation
  • Oxidative stress cascade response research
  • Neuronal apoptosis pathway signaling

This body of research has positioned Semax as a relevant compound for laboratories studying stroke, traumatic brain injury (TBI) models, and cerebrovascular disease research frameworks.

🔬 Supporting research:


How Semax Fits Into Broader Peptide Research

Semax sits within a growing area of research interest that bridges neuropeptide signaling, neurotrophin biology, and neuroprotection modeling.

Researchers studying Semax frequently explore it alongside other CNS-active peptides and compounds, including:

  • Selank — studied for anxiolytic signaling and GABA system interaction
  • Cerebrolysin — neurotrophic factor signaling models
  • MOTS-c — mitochondrial signaling and metabolic-neuro interaction models

🔗 Related internal reading:


View Our Research Peptides For Sale


Final Takeaway: Semax in Research

If you’re evaluating Semax for laboratory research, here’s the summary:

  • Semax is a synthetic ACTH-derived heptapeptide studied primarily in CNS signaling models
  • Its primary research relevance involves BDNF upregulation, neuroprotective signaling, and cognitive pathway modeling
  • It interacts with melanocortin receptors without triggering HPA axis activation — a key differentiator in stress-pathway research
  • Laboratory interest spans cognitive function, ischemia, neuroinflammation, and monoaminergic system studies

As neuropeptide research continues to expand, Semax remains one of the more well-characterized synthetic peptides available for CNS-focused laboratory investigation.


Sources & Further Reading

To support educational discussion and provide additional scientific context: